| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |